Aurobindo Pharma establishes new Chilean subsidiary

Aurobindo Pharma Limited has announced the incorporation of Eugia Pharma Chile SpA, a new wholly owned stepdown subsidiary, in Chile. This entity was formed by Eugia Pharma B.V., a wholly owned stepdown subsidiary of Aurobindo Pharma, with the primary objective of expanding Aurobindo Pharma’s pharmaceutical products business into Chile.

Eugia Pharma Chile SpA was officially incorporated on October 7, 2025. The new subsidiary's share capital amounts to CLP 1,000,000, divided into 100 shares, each with a nominal value of CLP 10,000. Aurobindo Pharma holds a 100% equity stake through a cash subscription.

As Eugia Pharma Chile SpA is a wholly owned stepdown subsidiary, its acquisition is classified as a related party transaction. However, Aurobindo Pharma confirmed that its promoters and promoter group have no interest in the transaction. No governmental or regulatory approvals were required for this incorporation.